About
X4 Pharmaceuticals Inc (NASDAQ:XFOR) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 17 2026
X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 4 2026
X4 Pharmaceuticals to Participate in a Fireside Chat at the Leerink Global Healthcare Conference
Mar 2 2026
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 27 2026
X4 Pharmaceuticals Receives Positive Opinion from the EMA CHMP Recommending Approval of Mavorixafor in the EU for WHIM Syndrome
Feb 3 2026
X4 Pharmaceuticals to Participate in Guggenheim’s Emerging Outlook: Biotech Summit 2026
Financials
Revenue
$35.11 M
Market Cap
$370.04 M
EPS
-1.87
Translate